Comerica Bank’s Oncolytics Biotech ONCY Stock Holding History

Comerica Bank’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$29K	Hold	15,526	–	–	﹤0.01%	2121
2022 Q3	$20K	Hold	15,526	–	–	﹤0.01%	2122
2022 Q2	$16K	Hold	15,526	–	–	﹤0.01%	2148
2022 Q1	$22K	Hold	15,526	–	–	﹤0.01%	2154
2021 Q4	$31K	Hold	15,526	–	–	﹤0.01%	2149
2021 Q3	$35K	Hold	15,526	–	–	﹤0.01%	2199
2021 Q2	$32K	Hold	15,526	–	–	﹤0.01%	2330
2021 Q1	$47K	Hold	15,526	–	–	﹤0.01%	2314
2020 Q4	$40K	Hold	15,526	–	–	﹤0.01%	2310
2020 Q3	$35K	Hold	15,526	–	–	﹤0.01%	2277
2020 Q2	$33K	Hold	15,526	–	–	﹤0.01%	2250
2020 Q1	$21K	Hold	15,526	–	–	﹤0.01%	2239
2019 Q4	$41K	Hold	15,526	–	–	﹤0.01%	2259
2019 Q3	$8K	Hold	15,526	–	–	﹤0.01%	2269
2019 Q2	$26K	Hold	15,526	–	–	﹤0.01%	2281
2019 Q1	$29K	Hold	15,526	–	–	﹤0.01%	2260
2018 Q4	$31K	Hold	15,526	–	–	﹤0.01%	2252
2018 Q3	$48K	Hold	15,526	–	–	﹤0.01%	2252
2018 Q2	$83K	Buy	+15,526	New	+$95.6K	﹤0.01%	2242

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Comerica Bank's ONCY Position: Q4 2022 in Review

Comerica Bank held its Oncolytics Biotech (ONCY) position steady in Q4 2022 at 15,526 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Comerica Bank first reported a position in ONCY in Q2 2018 and has held it in 19 quarters since. The position peaked at $83K in Q2 2018. 35 funds tracked by Wall St. Rank hold ONCY as of Q4 2022.

Comerica Bank held 15,526 shares of Oncolytics Biotech worth $29K as of Q4 2022.
Comerica Bank left its Oncolytics Biotech share count unchanged in Q4 2022.
Oncolytics Biotech made up ﹤0.01% of Comerica Bank's portfolio in Q4 2022, its #2121 holding.
Comerica Bank first reported a position in Oncolytics Biotech in Q2 2018 and has held it in 19 quarters since.
Comerica Bank's Oncolytics Biotech position peaked at $83K in Q2 2018.
35 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q4 2022.

Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.